Author: Dr. Linda Morrow – March 25th, 2021 Imagine a pandemic without having to shut down our lives. Imagine governments and industry working cooperatively to develop diagnostic and vaccine …
News
Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
Relief to potentially pay Acer up to $36 million and royalties in exchange for net profit share and territory rights ACER-001 pre-NDA meeting with U.S. FDA scheduled in Q2 2021 GENEVA, SWITZERLAND and …
Access Vascular, Inc. Secures $20 Million in Series B Financing
Bedford, MA – 03 March, 2021- Access Vascular, Inc., a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing. …
Kent’s deal with Net Health to expand Snapshot’s footprint
By David Godkin, Staff WriterTORONTO – Think of it. More than 14,000 facilities boasting 98% of the largest hospital chains across the U.S., two-thirds of skilled nursing facilities and hospice …
TVM Life Science Innovation II SCSp Announces Investment in Vespina Lifesciences Inc.
Luxembourg, February 1st, 2021 – TVM Life Science Innovation II SCSp today announced the Fund’s investment establishing Vespina Lifesciences Inc., a company based in Newark, Delaware. Vespina …
TVM Life Science Innovation II SCSp Announces Investment in Sarkana Pharma, Inc.
Luxembourg, February 1st, 2021 –TVM Life Science Innovation II SCSp today announced the fund’s investment establishing Sarkana Pharma, Inc., a company based in Wilmington, Delaware. Sarkana …